{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:58:25Z","timestamp":1790373505339,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020487","name":"Break Through Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020487","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Device"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.device.2026.101305","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:33:15Z","timestamp":1790263995000},"page":"101305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A fluidic-shear device for minimally disruptive, site-selective collection of viable cells from excised fallopian-tube tissue"],"prefix":"10.1016","author":[{"given":"Domitille","family":"Avalle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1529-422X","authenticated-orcid":false,"given":"Bert J.C.","family":"Vandereydt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"Parks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaiyao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Belcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kripa K.","family":"Varanasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.device.2026.101305_bib1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/520609a","article-title":"Personalized medicine: time for one-person trials","volume":"520","author":"Schork","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.device.2026.101305_bib2","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.fertnstert.2018.05.006","article-title":"Personalized medicine: motivation, challenges, and progress","volume":"109","author":"Goetz","year":"2018","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.device.2026.101305_bib3","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3390\/cancers12041009","article-title":"Personalized medicine: recent progress in cancer therapy","volume":"12","author":"Gambardella","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.device.2026.101305_bib4","first-page":"1351","article-title":"Patient-derived organoids in precision cancer medicine","volume":"5","author":"Tong","year":"2024","journal-title":"M\u00e9d. Sur"},{"key":"10.1016\/j.device.2026.101305_bib5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41698-025-00863-3","article-title":"Real-world experience of molecular tumour boards for clinical decision-making for cancer patients","volume":"9","author":"Herrero Colomina","year":"2025","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.device.2026.101305_bib6","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1158\/2159-8290.CD-23-1194","article-title":"Precision oncology: 2023 in review","volume":"13","author":"Murciano-Goroff","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.device.2026.101305_bib7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s43018-022-00332-x","article-title":"The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology","volume":"3","author":"Tamborero","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.device.2026.101305_bib8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13045-022-01351-y","article-title":"Liquid biopsy: current technology and clinical applications","volume":"15","author":"Nikanjam","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.device.2026.101305_bib9","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1053\/j.gastro.2011.07.050","article-title":"Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett\u2019s epithelium","volume":"141","author":"Sato","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.device.2026.101305_bib10","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","article-title":"Prospective derivation of a living organoid biobank of colorectal cancer patients","volume":"161","author":"van de Wetering","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.device.2026.101305_bib11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","article-title":"A living biobank of breast cancer organoids captures disease heterogeneity","volume":"172","author":"Sachs","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.device.2026.101305_bib12","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/nprot.2012.097","article-title":"Primary culture and immortalization of human fallopian tube secretory epithelial cells","volume":"7","author":"Karst","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.device.2026.101305_bib13","doi-asserted-by":"crossref","first-page":"26580","DOI":"10.1073\/pnas.1911273116","article-title":"Pancreatic cancer organoids recapitulate disease and allow personalized drug screening","volume":"116","author":"Driehuis","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.device.2026.101305_bib14","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.cell.2018.11.021","article-title":"Organoid modeling of the tumor immune microenvironment","volume":"175","author":"Neal","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.device.2026.101305_bib15","doi-asserted-by":"crossref","first-page":"6916","DOI":"10.18632\/oncotarget.6870","article-title":"Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4\/HH signaling loop","volume":"7","author":"Coffman","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.device.2026.101305_bib16","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/s41586-018-0670-5","article-title":"DYNLL1 binds to MRE11 to limit DNA end resection in BRCA1-deficient cells","volume":"563","author":"He","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.device.2026.101305_bib17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.celrep.2015.12.046","article-title":"Platinum and PARP inhibitor resistance due to overexpression of microRNA-622 in BRCA1-mutant ovarian cancer","volume":"14","author":"Choi","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.device.2026.101305_bib18","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s43018-021-00203-x","article-title":"A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumors","volume":"2","author":"Zhou","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.device.2026.101305_bib19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-cancerbio-030617-050422","article-title":"The Fanconi anemia pathway in cancer","volume":"3","author":"Niraj","year":"2019","journal-title":"Ann. Rev. Cancer Biol."},{"key":"10.1016\/j.device.2026.101305_bib20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ccell.2021.12.004","article-title":"Functional precision oncology: testing tumors with drugs to identify vulnerabilities and novel combinations","volume":"40","author":"Letai","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.device.2026.101305_bib21","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.aao2774","article-title":"Patient-derived organoids model treatment response of metastatic gastrointestinal cancers","volume":"359","author":"Vlachogiannis","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.device.2026.101305_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay2574","article-title":"Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients","volume":"11","author":"Ooft","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.device.2026.101305_bib23","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1158\/2159-8290.CD-18-0349","article-title":"Organoid profiling identifies common responders to chemotherapy in pancreatic cancer","volume":"8","author":"Tiriac","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.device.2026.101305_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.stem.2019.10.010","article-title":"Patient-derived organoids predict chemoradiation responses of locally advanced rectal cancer","volume":"26","author":"Yao","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.device.2026.101305_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2024.107533","article-title":"Ex vivo drug testing of patient-derived lung organoids to predict treatment responses for personalized medicine","volume":"190","author":"Taverna","year":"2024","journal-title":"Lung Cancer"},{"key":"10.1016\/j.device.2026.101305_bib26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","article-title":"Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models","volume":"24","author":"Perets","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.device.2026.101305_bib27","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1158\/2159-8290.CD-24-0805","article-title":"Aged and BRCA-mutated stromal cells drive epithelial cell transformation","volume":"15","author":"Garcia","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.device.2026.101305_bib28","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube","volume":"8","author":"Labidi-Galy","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.device.2026.101305_bib29","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1158\/2159-8290.CD-16-0607","article-title":"Genomics of ovarian cancer progression reveals diverse metastatic trajectories including intraepithelial metastasis to the fallopian tube","volume":"6","author":"Eckert","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.device.2026.101305_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/path.5219","article-title":"Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions","volume":"248","author":"Wu","year":"2019","journal-title":"J. Pathol."},{"key":"10.1016\/j.device.2026.101305_bib31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s13224-018-1155-z","article-title":"Evaluation of SEE-FIM (sectioning and extensively examining the FIMbriated end) protocol in identifying fallopian tube precursor lesions in women with ovarian tumors","volume":"69","author":"Arora","year":"2019","journal-title":"J. Obstet. Gynaecol. India"},{"key":"10.1016\/j.device.2026.101305_bib32","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1038\/s41467-020-16432-0","article-title":"Assessing the origin of high-grade serous ovarian cancer using CRISPR modification of mouse organoids","volume":"11","author":"L\u00f5hmussaar","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.device.2026.101305_bib33","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ygyno.2025.10.038","article-title":"Human fallopian tube epithelial organoids with TP53 mutation recapitulate features of serous tubal intraepithelial carcinoma (STIC)","volume":"203","author":"Kraiczy","year":"2025","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.device.2026.101305_bib34","series-title":"Stem Cell Assays: Methods and Protocols","first-page":"445","article-title":"Protocol for the detection of organoid-initiating cell activity in patient-derived single fallopian tube epithelial cells","author":"Feng","year":"2022"},{"key":"10.1016\/j.device.2026.101305_bib35","doi-asserted-by":"crossref","first-page":"S248","DOI":"10.1016\/j.ygyno.2024.07.365","article-title":"Generation of an organoid model of a STIC lesion from a MADM mouse model for premalignant ovarian cancer","volume":"190","author":"Chokshi","year":"2024","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.device.2026.101305_bib36","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/cncy.22110","article-title":"Cytomorphologic and molecular analyses of fallopian tube fimbrial brushings for diagnosis of serous tubal intraepithelial carcinoma","volume":"127","author":"Chui","year":"2019","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.device.2026.101305_bib37","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1159\/000353825","article-title":"Cytologic findings in experimental in vivo fallopian tube brush specimens","volume":"57","author":"Rodriguez","year":"2013","journal-title":"Acta Cytol."},{"key":"10.1016\/j.device.2026.101305_bib38","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jmig.2014.03.017","article-title":"Brush cytology of the fallopian tube and implications in ovarian cancer screening","volume":"21","author":"Lum","year":"2014","journal-title":"J. Minim. Invasive Gynecol."},{"key":"10.1016\/j.device.2026.101305_bib39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejogrb.2017.03.002","article-title":"Transvaginal laparoscopy: a minimally invasive approach to obtain brush cytology of the fallopian tube","volume":"212","author":"Gordts","year":"2017","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.device.2026.101305_bib40","article-title":"Externally tunable, low power electrostatic control of cell adhesion with nanometric high-k dielectric films","volume":"33","author":"Leon","year":"2023","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.device.2026.101305_bib41","article-title":"Reducing cancer cell adhesion using microtextured surfaces","volume":"19","author":"McCue","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.device.2026.101305_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adu3708","article-title":"Bubble-driven cell detachment","volume":"11","author":"Vandereydt","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.device.2026.101305_bib43","doi-asserted-by":"crossref","first-page":"38318","DOI":"10.1021\/acsnano.5c09950","article-title":"Alternating electrochemical redox-cycling on nanocomposite biointerface for high-efficiency enzyme-free cell detachment","volume":"19","author":"McCue","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.device.2026.101305_bib44","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1021\/acs.langmuir.4c03783","article-title":"Design of antibiofouling lubricant-impregnated surfaces robust to cell-growth-induced instability","volume":"41","author":"Kang","year":"2025","journal-title":"Langmuir"},{"key":"10.1016\/j.device.2026.101305_bib45","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1016\/j.biomaterials.2007.05.009","article-title":"The use of mild trypsinization conditions in the detachment of endothelial cells to promote subsequent endothelialization on synthetic surfaces","volume":"28","author":"Brown","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.device.2026.101305_bib46","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3727\/096368917X694831","article-title":"Effects of different cell-detaching methods on the viability and cell surface antigen expression of synovial mesenchymal stem cells","volume":"26","author":"Tsuji","year":"2017","journal-title":"Cell Transplant."},{"key":"10.1016\/j.device.2026.101305_bib47","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.bpj.2024.06.011","article-title":"Impact of trypsin on cell cytoplasm during detachment of cells studied by terahertz sensing","volume":"123","author":"Lordon","year":"2024","journal-title":"Biophys. J."},{"key":"10.1016\/j.device.2026.101305_bib48","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PAI.0b013e3182025f66","article-title":"Expression of PAX8 in normal and neoplastic tissues: a comprehensive immunohistochemical study","volume":"19","author":"Tacha","year":"2011","journal-title":"Appl. Immunohistochem. Mol. Morphol."}],"container-title":["Device"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666998626002577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666998626002577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:59:35Z","timestamp":1790369975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666998626002577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":48,"alternative-id":["S2666998626002577"],"URL":"https:\/\/doi.org\/10.1016\/j.device.2026.101305","relation":{},"ISSN":["2666-9986"],"issn-type":[{"value":"2666-9986","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A fluidic-shear device for minimally disruptive, site-selective collection of viable cells from excised fallopian-tube tissue","name":"articletitle","label":"Article Title"},{"value":"Device","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.device.2026.101305","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101305"}}